Skip to main content

Table 5 Competing risk model of clinical outcomes

From: The predictive effect of direct-indirect bilirubin ratio on clinical events in acute coronary syndrome: results from an observational cohort study in north China

 

Unadjusted HR (95% CI)

p value

Adjusted HR (95% CI)

p value

All-cause death

    
 

DIBIL ratio<0.20

Ref

 

Ref

 
 

0.20 ≤ DIBIL ratio<0.26

1.343 (1.024, 1.761)

0.033

1.269 (0.954, 1.688)

0.102

 

DIBIL ratio ≥ 0.26

2.220 (1.742, 2.829)

<0.001

1.829 (1.405, 2.381)

<0.001

CV death

    
 

DIBIL ratio<0.20

Ref

 

Ref

 
 

0.20 ≤ DIBIL ratio<0.26

1.202 (0.821, 1.760)

0.345

1.152 (0.772, 1.717)

0.489

 

DIBIL ratio ≥ 0.26

1.966 (1.392, 2.776)

<0.001

1.600 (1.103, 2.321)

0.013

Non-fatal MI

    
 

DIBIL ratio<0.20

Ref

 

Ref

 
 

0.20 ≤ DIBIL ratio<0.26

0.904 (0.696, 1.175)

0.452

0.922 (0.700, 1.215)

0.565

 

DIBIL ratio ≥ 0.26

0.955 (0.745, 1.225)

0.718

0.918 (0.689, 1.222)

0.556

Cardiac rehospitalization

    
 

DIBIL ratio<0.20

Ref

 

Ref

 
 

0.20 ≤ DIBIL ratio<0.26

0.958 (0.865, 1.060)

0.406

0.942 (0.847, 1.048)

0.272

 

DIBIL ratio ≥ 0.26

1.040 (0.945, 1.146)

0.423

0.997 (0.896, 1.110)

0.959

Revascularization

    
 

DIBIL ratio<0.20

Ref

 

Ref

 
 

0.20 ≤ DIBIL ratio<0.26

0.831 (0.684, 1.011)

0.064

0.839 (0.683, 1.029)

0.092

 

DIBIL ratio ≥ 0.26

0.985 (0.823, 1.178)

0.868

0.965 (0.791, 1.178)

0.725

Stroke

    
 

DIBIL ratio<0.20

Ref

 

Ref

 
 

0.20 ≤ DIBIL ratio<0.26

1.592 (1.025, 2.474)

0.039

1.378 (0.873, 2.175)

0.169

 

DIBIL ratio ≥ 0.26

1.586 (1.043, 2.412)

0.031

1.189 (0.756, 1.870)

0.453

Composite MACCEs

    
 

DIBIL ratio<0.20

Ref

 

Ref

 
 

0.20 ≤ DIBIL ratio<0.26

0.959 (0.866, 1.062)

0.419

0.945 (0.850, 1.052)

0.303

 

DIBIL ratio ≥ 0.26

0.991 (0.899, 1.092)

0.858

0.959 (0.862, 1.068)

0.451

  1. CV: cardiovascular, DIBIL: direct/indirect bilirubin ratio, MACCEs: Major Adverse Cardiac and Cerebrovascular events, MI: myocardial infarction